Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-27

Clinical Trial Update: Pepsinogen-1 Serum Levels in Hyperemesis Gravidarum

View source ↗

Summary

A clinical trial evaluating pepsinogen-1 serum levels in hyperemesis gravidarum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ankara Etlik City Hospital | Conditions: Hyperemesis Gravidarum, Pregnant With Complication | Status: COMPLETED